Thursday 18 Apr 2024
By
main news image

KUALA LUMPUR (August 8): CGS-CIMB Research has maintained its “Add” rating on Genetec Technology Bhd at RM2.42 with a lower target price (TP) of RM4.30 (from RM4.50) and said it expects Genetec to deliver stronger year-on-year and quarter-on-quarter net profit growth in 1QFY23F, driven by healthy order backlog from the electric vehicle (EV) & stationary energy storage (ES) segment.

In a note on Monday (Aug 8), the research house said Tesla’s plans to build up to 12 Gigafactories by 2030F will translate to healthy order visibility for Genetec.

“FY23-25F EPS lifted 7-12%.

“Reiterate Add with a lower RM4.30 TP, based on a lower 35x CY23F P/E,” it said.

 

 

      Print
      Text Size
      Share